BIOTECHNOLOGY SUPPORT ACT
Act No. 4938, Jan. 5, 1995
Amended by Act No. 4980, Dec. 6, 1995
Act No. 5400, Aug. 28, 1997
Act No. 6400, Jan. 29, 2001
Act No. 7014, Dec. 30, 2003
Act No. 7284, Dec. 31, 2004
Act No. 8852, Feb. 29, 2008
Act No. 9932, Jan. 18, 2010
Act No. 10872, Jul. 21, 2011
Act No. 11683, Mar. 23, 2013
Act No. 12844, Nov. 19, 2014
Act No. 14839, Jul. 26, 2017
Act No. 17261, May 19, 2020
Act No. 18649, Dec. 28, 2021
Act No. 20257, Feb. 13, 2024
Act No. 20475, Oct. 22, 2024
CHAPTER I GENERAL PROVISIONS
The purpose of this Act is to build the foundation for biotechnology research, foster and develop biotechnology efficiently, and promote the industrialization of the developed technologies, thereby contributing to the sound development of the national economy and the improvement of the quality of life of the people. <Amended on May 19, 2020>
[This Article Wholly Amended on Mar. 23, 2013]
The terms used in this Act are defined as follows: <Amended on May 19, 2020; Dec. 28, 2021>
| 1. | The term "biotechnology" means the science and technology that researches and utilizes biological systems, living bodies, genomes of organisms or other substances and information originating therefrom and includes basic medical sciences; |
| 2. | The term "basic medical sciences" means disciplines, such as physiology, pathology and pharmacology, that provide fundamental knowledge for biotechnology through research into the mechanisms of life phenomena, the cause of diseases, and the pathogenic processes; |
| 3. | The term "relevant central administrative agencies" means the Ministry of Economy and Finance, the Ministry of Education, the Ministry of Science and ICT, the Ministry of Foreign Affairs, the Ministry of Agriculture, Food and Rural Affairs, the Ministry of Trade, Industry and Energy, the Ministry of Health and Welfare, the Ministry of Environment, the Ministry of Oceans and Fisheries, the Ministry of SMEs and Startups, the Ministry of Food and Drug Safety, the Korean Intellectual Property Office, the Korea Disease Control and Prevention Agency, the Rural Development Administration, and the Korea Forest Service. |
[This Article Wholly Amended on Dec. 30, 2003]
| Article 3 (Responsibilities of the Government) |
| (1) | The Government shall formulate and implement comprehensive policy measures to promote technology development and industrialization in biotechnology to achieve the purpose of this Act. |
| (2) | Local governments shall formulate and implement policy measures to promote technology development and industrialization in biotechnology, reflecting national policy measures and local characteristics. |
| (3) | Enterprises, universities, research institutes, biotechnology-related entities and organizations, etc. shall actively perform the development of biotechnologies and make efforts to ensure that the results are useful. |
[This Article Added on May 19, 2020]
[Previous Article 3 moved to Article 4 <May 19, 2020>]
| Article 4 (Relationship to other statutes) |
Except as provided in other statutes, matters regarding biotechnology shall be governed by this Act. <Amended on Jan. 5, 1995; Mar. 23, 2013>
[Title Amended on May 19, 2020]
[Moved from Article 3; previous Article 4 moved to Article 5 <May 19, 2020>]
CHAPTER II PLANNING AND IMPLEMENTATION SYSTEM FOR BIOTECHNOLOGY SUPPORT
| Article 5 (Formulation of master plans for biotechnology development) |
| (1) | The head of each relevant central administrative agency shall submit a plan for biotechnology development for each field under his or her jurisdiction to the Minister of Science and ICT. <Amended on Mar. 23, 2013; Jul. 26, 2017; May 19, 2020> |
| (2) | The Minister of Science and ICT shall formulate a master plan for biotechnology development (hereinafter referred to as the "master plan") by integrating and coordinating the biotechnology development plans submitted by the heads of the relevant ministries and agencies under paragraph (1) relating to the matters under their jurisdictions. <Amended on Mar. 23, 2013; Jul. 26, 2017> |
| (3) | The master plan shall include the following matters: <Amended on Jan. 5, 1995; Aug. 28, 1997; Mar. 23, 2013; May 19, 2020> |
| 1. | Mid- to long-term policy goals and direction for promoting technology development and industrialization in biotechnology; |
| 2. | Biotechnology research and development, including basic and original research in biotechnology, industrial application research, and convergence research; |
| 3. | Protection and utilization of intellectual property rights and promotion of technology transfer and commercialization of biotechnology results; |
| 4. | Fostering and support of biotechnology-related industries and promotion of starting up of businesses; |
| 5. | Establishment of and support for the biotechnology infrastructure, including biotechnology-related human resources, information, statistics, and facilities; |
| 6. | Investment expansion and financing plans to promote technology development and industrialization in biotechnology; |
| 7. | Cooperation among biotechnology-related enterprises, universities, research institutes, and medical institutions; |
| 8. | Promotion of international cooperation related to biotechnology and support for overseas expansion; |
| 9. | Establishment and improvement of systems for promoting technology development and industrialization in biotechnology; |
| 10. | Other important matters regarding the promotion of technology development and industrialization in biotechnology. |
| (4) | The Minister of Science and ICT shall finalize the master plan after deliberation by the Biotechnology Comprehensive Policy Council under Article 7. <Amended on Mar. 23, 2013; Jul. 26, 2017; May 19, 2020> |
| (5) | Except as provided in paragraphs (1) through (4), matters necessary for the formulation of master plans shall be prescribed by Presidential Decree. <Added on May 19, 2020> |
[Moved from Article 4; previous Article 5 moved to Article 6 <May 19, 2020>]
| Article 6 (Formulation and implementation of annual implementation plans) |
| (1) | The head of each relevant central administrative agency shall formulate and implement an annual implementation plan (hereinafter referred to as "implementation plan") to promote technology development and industrialization in the fields of biotechnology under his or her jurisdiction in accordance with the master plan; provided, an implementation plan for the fields under the jurisdiction of the Administrator of the Rural Development Administration and the Minister of the Korea Forest Service shall be formulated and implemented by the Minister of Agriculture, Food and Rural Affairs. <Amended on Mar. 23, 2013; May 19, 2020; Dec. 28, 2021> |
| (2) | When the heads of the relevant central administrative agencies intend to formulate their implementation plans, they shall consult with the Minister of Science and ICT in advance. <Amended on Mar. 23, 2013; Jul. 26, 2017; May 19, 2020> |
| (3) | The Minister of Science and ICT, if deemed necessary, may prepare basic guidelines necessary for formulating an implementation plan and inform the heads of the relevant central administrative agencies thereof. <Amended on Mar. 23, 2013; Jul. 26, 2017; May 19, 2020> |
| (4) | Matters necessary for the formulation and implementation of implementation plans shall be prescribed by Presidential Decree. <Amended on Mar. 23, 2013> |
[Title Amended on May 19, 2020]
[Moved from Article 5; previous Article 6 moved to Article 7 <May 19, 2020>]
| Article 7 (Biotechnology Comprehensive Policy Council) |
| (1) | A Biotechnology Comprehensive Policy Council shall be established under the authority of the Minister of Science and ICT (hereinafter referred to as the "Council") to oversee the formulation of master plans, detailed strategies and plans for promoting technology development and industrialization in biotechnology, and the execution and coordination thereof. <Amended on Mar. 23, 2013; Jul. 26, 2017; May 19, 2020> |
| (2) | The Council shall deliberate and decide on the following matters: <Amended on Jan. 5, 1995; Aug. 28, 1997; Dec. 30, 2003; Feb. 29, 2008; Jul. 21, 2011; Mar. 23, 2013; Jul. 26, 2017; May 19, 2020; Oct. 22, 2024> |
| 1. | Formulation and implementation of the master plan and implementation plans and coordination thereof; |
| 2. | Establishment and coordination of important policies on technology development and industrialization in biotechnology; |
| 3. | Establishment and maintenance of major biotechnology-related systems and improvements thereto; |
| 3-2. | Designation of promising biotechnologies, change or revocation of designation thereof; |
| 4. | Deleted; <May 19, 2020> |
| 5. | Deleted; <May 19, 2020> |
| 8. | Deleted; <May 19, 2020> |
| 9. | Deleted; <May 19, 2020> |
| 10. | Other matters deemed necessary the Minister of Science and ICT for fostering biotechnology and promoting brain research. |
| (3) | The Council shall consist of up to 17 members, including 1 chairperson. <Added on Dec. 30, 2003> |
| (4) | The chairperson shall be the Minister of Science and ICT, and the members shall be as follows: <Added on Dec. 30, 2003; Feb. 29, 2008; Mar. 23, 2013; Jul. 26, 2017; May 19, 2020> |
| 1. | Vice-ministerial level public officials of the relevant central administrative agencies who are prescribed by Presidential Decree; |
| 2. | Persons commissioned by the Minister of Science and ICT from among biotechnology-related persons and bioethics experts working in academia, research institutes, medical institutions, or industry. |
| (5) | The Council may establish a working committee to review deliberations under paragraph (2) in advance and to handle tasks entrusted by the Council. <Added on May 19, 2020> |
| (6) | Other matters necessary for the organization, composition, operation, etc. of the Council and the working committee shall be prescribed by Presidential Decree. <Added on Dec. 30, 2003; May 19, 2020> |
[Moved from Article 6 <May 19, 2020>]
| Article 8 (Establishment of policy measures to foster biotechnology) |
| (1) | The Government shall devise and proceed with comprehensive policy measures for the basic research in biotechnology and the research on its industrial application in order to efficiently foster the biotechnology: <Amended on Aug. 28, 1997; Jan. 29, 2001; Dec. 30, 2003; Dec. 31, 2004; Feb. 29, 2008; Jan. 18, 2010; Mar. 23, 2013; Nov. 19, 2014; Jul. 26, 2017; May 19, 2020> |
| 1. | Deleted; <May 19, 2020> |
| 2. | Deleted; <May 19, 2020> |
| 3. | Deleted; <May 19, 2020> |
| 4. | Deleted; <May 19, 2020> |
| 4-2. | Deleted; <Feb. 29, 2008> |
| 5. | Deleted; <May 19, 2020> |
| 6. | Deleted; <May 19, 2020> |
| 7. | Deleted. <May 19, 2020> |
| (2) | The promotion and fostering of research and development in the field of basic medical sciences shall be the responsibility of the Minister of Science and ICT and the Minister of Health and Welfare, and they shall consult when they intend to establish policy measures to foster basic medical sciences. <Amended on May 19, 2020> |
| (3) | The head of each relevant central administrative agency shall devise detailed policy measures for each field under his or her jurisdiction, which are necessary for promoting the development and industrialization of biotechnologies. <Added on May 19, 2020> |
| (4) | Matters necessary for the content and scope of the detailed policy measures under paragraph (3) shall be prescribed by Presidential Decree. <Added on May 19, 2020> |
[This Article Wholly Amended on Jan. 5, 1995]
[Moved from Article 13 <May 19, 2020>]
| Article 9 (Fact-finding survey) |
| (1) | The head of each relevant central administrative agency may conduct a fact-finding survey on technology development and industrialization in biotechnology so as to secure basic data necessary for promoting the technology development and industrialization in biotechnology. |
| (2) | The head of each relevant central administrative agency may request the submission of necessary materials from the heads of other relevant central administrative agencies, the Special Metropolitan City Mayor, Metropolitan City Mayors, Do Governors, the Special Self-Governing Province Governors, the heads of enterprises, universities, research institutes, medical institutions, and the heads of other public institutions or organizations if necessary for a fact-finding survey under paragraph (1). |
| (3) | A person requested to submit materials under paragraph (2) shall cooperate therewith unless there is a compelling reason not to do so, such as that the materials fall under the category of sensitive information under Article 23 of the Personal Information Protection Act. |
| (4) | Matters necessary for the methods and procedures of fact-finding surveys under paragraph (2) shall be prescribed by Presidential Decree. |
[This Article Added on May 19, 2020]
[Previous Article 9 moved to Article 13 <May 19, 2020>]
| Article 10 (Technology impact assessment) |
| (1) | The Minister of Science and ICT shall conduct a prior assessment on impact of the developments of new biotechnology on economy, society, culture, ethics, environment, etc. (hereinafter referred to as "technology impact assessment"), and reflect results thereof in the policies. |
| (2) | Matters necessary for the procedures for and the method of technology impact assessment shall be prescribed by Presidential Decree. |
[This Article Added on May 19, 2020]
[Previous Article 10 moved to Article 12 <May 19, 2020>]
CHAPTER III PROMOTION OF RESEARCH AND DEVELOPMENT OF BIOTECHNOLOGY
| Article 11 (Promotion of research and development programs) |
| (1) | The Government shall conduct research and development programs for biotechnology research and technology development in order to efficiently achieve the purpose of this Act. |
| (2) | The head of each relevant central administrative agency may, if necessary, select a research project to promote a research and development program and conclude an agreement with a company, university, research institute, medical institution, or an entity or organization related to biotechnology to assign it to research. |
| (3) | The Government may subsidize entities and organizations that implement research and development programs under paragraph (2) to cover all or some of the expenses incurred for the research and development programs. |
[This Article Added on May 19, 2020]
[Previous Article 11 moved to Article 15 <May 19, 2020>]
| Article 11-2 (Designation of promising biotechnologies) |
| (1) | The Minister of Science and ICT may designate and support promising biotechnologies after deliberation by the Council in order to promote biotechnology research and technology development. |
| (2) | When designating promising biotechnologies under paragraph (1), the following matters may be comprehensively considered: |
| 1. | Conformity with relevant major policies, such as master plans and implementation plans; |
| 2. | Challenging and innovative nature of technology development; |
| 3. | Contribution to the creation of new technologies and new industries and spillovers to related industries; |
| 4. | Necessity of securing technology in terms of national security; |
| 5. | Other matters deemed important by the Council. |
| (3) | Where it is necessary to change or revoke the designation of a promising biotechnology, the Minister of Science and ICT may revoke the designation of the promising biotechnology after deliberation by the Council. |
| (4) | The Minister of Science and ICT shall publicly notify designation under paragraph (1) or change or revocation of designation under paragraph (3), if any. |
| (5) | Matters necessary for procedures for designation of promising biotechnologies under paragraph (1), including demand surveys and requests for designation, scope and content of support, procedures for change or revocation of designation under paragraph (3) shall be prescribed by presidential decree. |
[This Article Added on Oct. 22, 2024]
| Article 12 (Promotion of joint or convergence research) |
| (1) | The Government shall promote joint or convergence research among academia, research institutes, medical institutions, and industry to efficiently foster biotechnology research and technology development. <Amended on May 19, 2020> |
| (2) | In order to promote convergence research between technologies, including the combination of biotechnology with technologies in other research fields, such as artificial intelligence technology or information and communications technology, the Government may implement the following projects: <Added on Oct. 22, 2024> |
| 1. | Research and development projects related to biotechnology convergence research; |
| 2. | Expansion of infrastructure, such as research equipment and facilities related to biotechnology convergence research; |
| 3. | Support for the commercialization of outcomes of technological innovation related to biotechnology convergence research; |
| 4. | Systematic education and development of the professional workforce in biotechnology convergence research; |
| 5. | Other projects necessary for the promotion of biotechnology convergence research. |
| (3) | Matters necessary for the promotion of joint or convergence research as specified in paragraphs (1) and (2) shall be prescribed by Presidential Decree. <Added on May 19, 2020; Oct. 22, 2024> |
[This Article Wholly Amended on Mar. 23, 2013]
[Title Amended on May 19, 2020]
[Moved from Article 10; previous Article 12 moved to Article 19 <May 19, 2020>]
| Article 13 (Promotion of international cooperation) |
| (1) | The Government shall identify international trends and actively promote international cooperation in order to improve the level of biotechnology and activate exchanges. <Amended on Jul. 26, 2017; May. 19, 2020; Oct. 22, 2024> |
| (2) | The Government may conduct the following projects in cooperation with foreign governments, international organizations, research and development institutes and organizations, etc. in order to promote international cooperation under paragraph (1); in such cases, the Government may allow Korean enterprises, universities, research institutes, medical institutions, biotechnology-related entities and organizations, etc. that desire to participate in such projects: <Added on Oct. 22, 2024> |
| 1. | International joint research on biotechnology; |
| 2. | Technology and workforce exchange on biotechnology; |
| 3. | Promotion of the exchange and joint utilization of information and knowledge on biotechnology; |
| 4. | Technical cooperation in the construction and operation of research and development facilities and equipment related to biotechnology; |
| 5. | Establishment of and support for collaborative hubs, such as joint research centers in the field of biotechnology; |
| 6. | Other matters prescribed by Presidential Decree as necessary in connection with international cooperation. |
| (3) | The Government may provide necessary support within the budget to enterprises, universities, research institutes, medical institutions, biotechnology-related entities and organizations, etc. that jointly participate in accordance with the latter part, with the exception of the subparagraphs, of paragraph (2). <Added on Oct. 22, 2024> |
[This Article Wholly Amended on Mar. 23, 2013]
[Title Amended on May 19, 2020]
[Moved from Article 9; previous Article 13 moved to Article 8 <May 19, 2020>]
| Article 14 (Preparation and implementation of experimental guidelines) |
| (1) | The Government shall prepare and implement experimental guidelines for the promotion of technology research and industrialization in biotechnology. <Amended on Mar. 23, 2013> |
| (2) | The experimental guidelines under paragraph (1) shall provide for measures necessary to prevent the occurrence of biohazards, adverse environmental impacts, and ethical problems that may be foreseen in the course of biotechnology research and its industrialization, and shall establish safety standards for the transfer, handling, and use of genetically modified organisms. <Amended on Mar. 23, 2013> |
[Moved from Article 15; previous Article 14 moved to Article 17 <May 19, 2020>]
CHAPTER IV PROMOTION OF BIOTECHNOLOGY INDUSTRIALIZATION
| Article 15 (Support for promotion of industrial applications of biotechnology) |
| (1) | The Government shall devise policy measures to support the following matters in order to invigorate biotechnology research and development and promote the industrial application of the results: <Amended on May 19, 2020; Oct. 22, 2024> |
| 1. | Follow-up research and development for industrial application of biotechnology; |
| 2. | Research on convergence of biotechnology and other fields; |
| 3. | Research on and service development of promising general-purpose technologies (referring to base technology utilized for general purposes in production and use of products or services related to biotechnology) of biotechnology; |
| 4. | Promotion of technology transfer and commercialization in relation to biotechnology; |
| 5. | Promotion of creation, protection, and utilization of intellectual property on biotechnology; |
| 6. | Establishment of regional hubs to promote biotechnology research and development and industrialization; |
| 7. | Facilitation of the production and sales of new technology products related to biotechnology; |
| 8. | Other matters to promote industrial application of biotechnology. |
| (2) | The Government may provide the following support to promote biotechnology-related commercialization: <Added on Oct. 22, 2024> |
| 1. | Subsidization of expenses incurred for the demonstration of biotechnology results, the development and production of prototypes, and facility investment; |
| 2. | Education and publicity on developed biotechnology-related technologies and products; |
| 3. | Other matters prescribed by Presidential Decree as necessary for promoting commercialization. |
[This Article Wholly Amended on Dec. 30, 2003]
[Title Amended on Dec. 22, 2024]
[Moved from Article 11; previous Article 15 moved to Article 14 <May 19 2020>]
| Article 16 (Fostering and support of biotechnology innovators) |
| (1) | In order to invigorate industry in the field of biotechnology, the Government shall devise policy measure to foster and support various innovative entities, such as academia, research institutes, medical institutions, and industry. |
| (2) | The Government may identify and foster prospective entrepreneurs and business starters and implement projects to support their overseas expansion, etc. in order to facilitate starting up of businesses in the field of biotechnology. |
[This Article Added on May 19, 2020]
[Previous Article 16 moved to Article 23 <May 19, 2020>]
| Article 17 (Testing and clinical trials) |
| (1) | The Government shall establish a system for clinical trials and testing of biotechnological products. <Amended on Mar. 23, 2013> |
| (2) | Matters necessary for the establishment of clinical trials and testing systems under paragraph (1) shall be prescribed by the Presidential Decree. <Amended on Mar. 23, 2013> |
[Moved from Article 14; previous Article 17 moved to Article 25 <May 19, 2020>]
CHAPTER V LAYING FOUNDATIONS FOR BIOTECHNOLOGY
| Article 18 (Training of professional workforce) |
| (1) | The Government shall formulate policy measures for training the professional workforce in order to efficiently respond to the demand for workforce for technology development and industrialization in biotechnology. <Amended on Oct. 22, 2024> |
| (2) | The Minister of Science and ICT shall, in consultation with the heads of the relevant central administrative agencies, forecast the supply of and demand for workforce for technology development and industrialization in biotechnology and endeavor to reflect the results thereof in the master plan and policy measures under paragraph (1). <Added on Oct. 22, 2024> |
| (3) | The Government may promote the following projects in cooperation with industry, universities, research institutes, medical institutions, etc. in order to train the professional workforce necessary for technology development and industrialization in biotechnology: <Added on Oct. 22, 2024> |
| 1. | Industry-academia-research cooperation projects for training biotechnology-related professional workforce; |
| 2. | Dispatch of domestic biotechnology-related professionals to overseas research institutes and biotechnology-related entities and organizations; |
| 3. | Support for the attraction of international biotechnology-related professionals; |
| 4. | Other projects prescribed by Presidential Decree to train professional workforce necessary for the promotion of technology development and industrialization in biotechnology. |
[This Article Added on May 19, 2020]
| Article 19 (Collection, management, and utilization of biotechnology information) |
| (1) | The Government shall formulate plans to systematically and comprehensively collect, manage, and utilize information on biotechnology in order to invigorate biotechnology research and development and to promote the industrialization thereof. |
| (2) | The Minister of Science and ICT shall periodically investigate information in order to collect, manage, and utilize biotechnology-related information and may request biotechnology information and related materials from the relevant central administrative agencies, national or public research institutes, etc. if necessary. |
| (3) | Details necessary for the scope of biotechnology information under paragraph (2), timing for investigation, institutes to be engaged in the investigation, etc. shall be prescribed by Presidential Decree. |
[This Article Wholly Amended on May 19, 2020]
[Moved from Article 12; previous Article 19 moved to Article 26 <May 19, 2020>]
| Article 20 (Establishment of classification system) |
| (1) | The heads of relevant central administrative agencies shall establish and continuously supplement and develop a biotechnology classification system for the efficient management of information, human resources, technology, products, and services in the field of biotechnology. |
| (2) | Matters necessary for the establishment of classification system under paragraph (1) shall be prescribed by Presidential Decree. |
[This Article Added on May 19, 2020]
| Article 20-2 (Promotion of standardization) |
| (1) | The Government may establish and implement the following policy measures regarding the standardization of biotechnologies in order to promote the development, transfer, diffusion, and industrialization of biotechnologies and to ensure compatibility between related technologies: |
| 1. | Development, dissemination, and spread of standards for biotechnologies; provided, with respect to the matters for which Korean industrial standards have been established under the Industrial Standardization Act, the standards shall apply; |
| 2. | Research and development and information investigation related to the standardization of biotechnologies; |
| 3. | International cooperation on the standardization of biotechnologies; |
| 4. | Other matters prescribed by Presidential Decree as necessary for the standardization of biotechnologies. |
| (2) | Matters necessary for the establishment and implementation of policy measures under paragraph (1) shall be prescribed by Presidential Decree. |
[This Article Added on Oct. 22, 2024]
| Article 21 (Surveys and analyses of biotechnology statistics) |
| (1) | The head of each relevant central administrative agency shall survey, analyze, and maintain relevant statistics in order to efficiently formulate policies for technology development and industrialization in biotechnology. |
| (2) | The head of each relevant central administrative agency may, if necessary for statistical surveys, etc. under paragraph (1), request related materials from the heads of other relevant central administrative agencies the heads of local governments, the heads of enterprises, universities, research institutes, and medical institutions, and the heads of other public institutions and organizations. |
| (3) | A person requested to submit materials under paragraph (2) shall cooperate therewith unless there is a compelling reason not to do so, such as that the materials fall under the category of sensitive information under Article 23 of the Personal Information Protection Act. |
| (4) | Matters necessary for the objects and methods of statistical surveys and analyses under paragraphs (1) and (2) shall be prescribed by Presidential Decree. |
[This Article Added on May 19, 2020]
| Article 22 (Biotechnology-related regulatory improvement) |
| (1) | The Government shall relax or eliminate unnecessary regulation hindering technological innovation and new industry creation in biotechnology and prepare systems or regulations copping with domestic and international environmental changes. |
| (2) | The head of each relevant central administrative agency shall gather the opinions from interested persons, experts, etc. on the regulation of technology development and utilization in biotechnology in order to identify regulatory gaps need to be improved, and review improvement plans. |
| (3) | Matters necessary for identifying regulatory gaps and reviewing improvement plans under paragraph (2) shall be prescribed by Presidential Decree. |
[This Article Added on May 19, 2020]
| Article 23 (Korea Research Institute of Bioscience and Biotechnology) |
| (1) | The Korea Research Institute of Bioscience and Biotechnology (hereinafter referred to as the "Research Institute"), an incorporated foundation, may be established to play a pivotal function in research on biotechnology (excluding research on basic medical sciences; hereafter in this Article the same shall apply) and research on the utilization and conservation of genetic resources, to maintain and develop a mutual cooperative system among academia, research institutes, and industry in the field of biotechnology, and to support them. <Amended on Jan. 5, 1995; Dec. 30, 2003; Mar. 23, 2013> |
| (2) | The Research Institute under paragraph (1) shall be a specific research institute subject to the Support of Specific Research Institutions Act. <Amended on Mar. 23, 2013> |
| (3) | Deleted. <Dec. 6, 1995> |
[Moved from Article 16 <May 19, 2020>]
| Article 24 (Designation of institute specializing in biotechnology policy) |
| (1) | The Minister of Science and ICT may designate an institute specializing in biotechnology policy (hereinafter referred to as the "Policy Center") to efficiently support the establishment and coordination of biotechnology policy and the development and utilization of biotechnologies. |
| (2) | The Government may fully or partially subsidize expenses incurred in conducting the business of the Policy Center within the budget. |
| (3) | Where the Policy Center designated under paragraph (1) falls under any of the following subparagraphs, the Minister of Science and ICT may revoke the designation thereof: <Added on Feb. 13, 2024> |
| 1. | Where it fails to meet the requirements for designation prescribed by Decree of the Ministry of Science and ICT; |
| 2. | Where it is unable to achieve the purpose of designating the Policy Center. |
| (4) | Other matters necessary for the designation, revocation of designation, and operation of the Policy Center shall be determined by the Minister of Science and ICT. <Amended on Feb. 13, 2024> |
[This Article Added on May 19, 2020]
| Article 25 (Medical science and engineering development support organization) |
| (1) | The Government may designate and operate a medical science and engineering development support organization (hereinafter referred to as the "development support organization"). |
| (2) | The Government may subsidize expenses incurred in operating the development support organization within the budget. |
| (3) | Matters necessary for the designation and operation of the development support organization shall be prescribed by the Presidential Decree. |
[This Article Added on Dec. 30, 2003]
[Moved from Article 17 <May 19, 2020>]
| Article 26 (Release of goods prior to acceptance of import declaration) |
| (1) | Deleted. <Dec. 30, 2003> |
| (2) | Goods from among materials, equipment, or reagents necessary for biotechnology research activities that are not produced domestically and that require urgent customs clearance due to deterioration or other reasons may be released prior to acceptance of import declaration as prescribed by the Presidential Decree, notwithstanding the provisions of the Customs Act. <Amended on Mar. 23, 2013> |
[Moved from Article 19 <May 19, 2020>]
| Article 27 (Delegation of authority or entrustment of tasks) |
| (1) | The Minister of Science and ICT may delegate part of his or her authority prescribed in this Act to the head of any other administrative agency or the head of any agency under his or her control as prescribed by Presidential Decree. |
| (2) | The tasks of the Minister of Science and ICT under this Act may be partially entrusted to biotechnoloy-related entities and organizations as prescribed by Presidential Decree. |
| (3) | The Minister of Science and ICT may fully or partially subsidize the expenses incurred for entrusted management under paragraph (2). |
[This Article Added on May 19, 2020]
| Article 28 (Legal fiction as public officials for purposes of applying penalty provisions) |
[This Article Added on May 19, 2020]
ADDENDUM <Act No. 3718, Dec. 31, 1983>
This Act shall enter into force on the two months following the date of its promulgation.
ADDENDA <Act No. 4268, Dec. 27, 1990>
Article 1 (Enforcement date)
This Act shall enter into force on the date of its promulgation. (Proviso Omitted.)
ADDENDA <Act No. 4541, Mar. 6, 1993>
Article 1 (Enforcement date)
This Act shall enter into force on the date of its promulgation.
ADDENDUM <Act No. 4938, Jan. 5, 1995>
This Act shall enter into force 6 months after the date of its promulgation.
ADDENDA <Act No. 4980, Dec. 6, 1995>
Article 1 (Enforcement date)
This Act shall enter into force on January 1, 1996. (Proviso Omitted.)
ADDENDUM <Act No. 5400, Aug. 28, 1997>
This Act shall enter into force 3 months after its promulgation.
ADDENDA <Act No. 6400, Jan. 29, 2001>
Article 1 (Enforcement date)
This Act shall enter into force on the date of its promulgation. (Proviso Omitted.)
ADDENDUM <Act No. 7014, Dec. 30, 2003>
This Act shall enter into force 6 months after the date of its promulgation.
ADDENDA <Act No. 7284, Dec. 31, 2004>.
Article 1 (Enforcement date)
This Act shall enter into force 6 months after the date of its promulgation.
ADDENDA <Act No. 8852, Feb. 29, 2008>
Article 1 (Enforcement date)
This Act shall enter into force on the date of its promulgation; provided, ... <omitted> ... the provisions amending any Act which was promulgated before this Act enters into force but has yet to enter into force, among the Acts amended by Article 6 of the Addenda, shall enter into force on the respective date the relevant Act enters into force.
ADDENDA <Act No. 9932, Jan. 18, 2010>
Article 1 (Enforcement date)
This Act shall enter into force 2 months after the date of its promulgation. (Proviso Omitted.)
ADDENDUM <Act No. 10872, Jul. 21, 2011>
This Act shall enter into force 3 months after the date of its promulgation.
ADDENDUM <Act No. 11683, Mar. 23, 2013>
This Act shall enter into force on the date of its promulgation.
ADDENDA <Act No. 12844, Nov. 19, 2014>
Article 1 (Enforcement date)
This Act shall enter into force on the date of its promulgation; provided, the provisions amending any Act which was promulgated before this Act enters into force but has yet to enter into force, among the Acts amended by Article 6 of the Addenda, shall enter into force on the respective date the relevant Act enters into force.
ADDENDA <Act No. 14839, Jul. 26, 2017>
Article 1 (Enforcement date)
| (1) | This Act shall enter into force on the date of its promulgation; provided, the provisions amending any Act that was promulgated before this Act enters into force but has yet to enter into force, among the Acts amended by Article 5 of the Addenda, shall enter into force on the respective date the relevant Act enters into force. |
ADDENDA <Act No. 17261, May 19, 2020>
Article 1 (Enforcement date)
This Act shall enter into force 6 months after the date of its promulgation.
Article 2 (Applicability to master plans)
The amended provisions of Article 5 (3) shall begin to apply to master plans formulated after this Act enters into force.
ADDENDUM <Act No. 18649, Dec. 28, 2021>
This Act shall enter into force 3 months after the date of its promulgation.
ADDENDUM <Act No. 20257, Feb. 13, 2024>
This Act shall enter into force 6 months after the date of its promulgation.
ADDENDUM <Presidential Decree No. 20475, Oct. 22, 2024>
This Act shall enter into force 6 months after the date of its promulgation.